You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 41.5 KDa. Observed: 57-60 KDa, reducing conditions
Human
Lys36-Asp161
C-Fc-Avi
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 54.2 KDa. Observed: 70-95 KDa, reducing conditions
Human
Phe19-Thr239
C-Fc-Avi
20 μg, 100 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.7 KDa. Observed: 60-70 KDa, reducing conditions
Human
Gln19-Pro139
C-Fc-Avi
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 29.8 KDa. Observed: 40-55 KDa, reducing conditions
Human
Ser27-Gly59(Ser44Thr)
C-Fc
1 mg, 10 μg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 26.1 KDa. Observed: 35-40 KDa, reducing conditions
Human
Gly42-Arg268
C-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.9 KDa. Observed: 35-40 KDa, reducing conditions
Mouse
Gly24-Lys238
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 47.8 KDa. Observed: 72 KDa, reducing conditions
Human
Gly24-His456
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 84.5 KDa. Observed: 94 KDa, reducing conditions
Mouse
Ala35-Thr794
C-6His
500 μg, 1 mg, 50 μg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.4 KDa. Observed: 45-55 KDa, reducing conditions
Human
Glu30-Glu362
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.7 KDa. Observed: 40-55 KDa, reducing conditions
Human
Met22-Pro141
C-Fc
500 μg, 1 mg, 10 μg, 50 μg